Clinical analysis of psoriatic inpatients - A 10-year retrospective study

Dermatologica Sinica

Volumn 25, Issue 2, 2007, Pages 103-111

  Yeh, Ming Hsiung ^a   Tsai, Tsen Fang ^b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Exacerbation; Inpatients; Psoriasis

Indexed keywords

ALCOHOL; CHINESE DRUG; STEROID;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CLIMATE CHANGE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIET THERAPY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEWBORN; OUTPATIENT CARE; PSORIASIS; RETROSPECTIVE STUDY; RISK FACTOR; SKIN INFECTION; TREATMENT FAILURE; UNIVERSITY HOSPITAL;

EID: 34250734906     PISSN: 10278117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. De Jong EM: The course of psoriasis. Clin Dermatol 15: 687-692, 1997.
2. Finlay AY, Kelly SE: Psoriasis: an index of disability. Clin Exp Dermatol 12: 8-11, 1987.
3. Ayyalaraju RS, MRCP, Finlay AY, et al.: Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a comparative study. J Am Acad Dermatol 49: 249-254, 2003.
4. Cockayne SE, Cork MJ, Gawkrodger DJ: Treatment of psoriasis: day care vs. inpatient therapy. Br J Dermatol 140: 375-376, 1999.
5. Stern RS: Inpatient hospital care for psoriasis: a vanishing practice in the United States. J Am Acad Dermatol 49: 445-450, 2003.
6. Chen HH, Tseng MP, Tsai TF: An epidemiologic study of Taiwanese psoriatic patients in a single clinic. Dermatol Sinica 21: 216-224, 2003.
7. Baker BS, Bokth S, Powles A, et al.: Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 128: 493-499, 1993.
8. Aiba S, Tagami H: Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432. Arch Dermatol Res 281: 310-315, 1989.
9. Baker BS, Powles AV, Malkani AK, et al.: Altered cell-mediated immunity to group A hemolytic streptococcal antigens in chronic plaque psoriasis. Br J Dermatol 125: 38-42, 1991.
10. McFadden J, Valdimarsson H, Fry L: Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 125: 443-447, 1991.
11. Valdimarsson H, Baker BS, Jonsdottir I, et al.: Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16: 145-149, 1995.
12. Yarwood JM, Leung DY, Schlievert PM: Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett 192: 1-7, 2000.
13. Lafon M: [Viral superantigens].[French] Rev Med Interne 21: 713-716, 2000.
14. Gottlieb A, Krueger JG, Bright R, et al.: Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 42: 428-435, 2000.
15. Raptiva [efalizumab] [package insert]. South San Francisco, CA: Genentech Inc, 2005.
16. Ryan T, Baker H: Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases. Br J Dermatol 81: 134-145, 1969.
17. Ryan T, Baker H: The prognosis of generalized pustular psoriasis. Br J Dermatol 85: 407-411, 1971.
18. Mengesha Y, Bennett M: Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol 3: 389-400, 2002.
19. Hellgren L: Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis. Ann Clin Res 8: 317-319, 1976.
20. Telfer NR, Dawer RP: Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate. J Am Acad Dermatol 17: 144-145, 1987.
21. Brush J, Mendenhall E, Guggenhem A, et al.: The effects of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytother Res [Epub ahead of print], 2006.
22. Block KI, Mead MN: Immune system effects of Echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2: 247-267, 2003.
23. Behnam SM, Behnam SE, Koo JY: Alcohol as a risk factor for plaque-type psoriasis. Cutis 76: 181-185, 2005.
24. Lin YL, Lee SS, Hou SM, et al.: Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune responses in BALB/c mice. Mol Pharmacol 70: 637-644, 2006.
25. Le Guyadec T, Saint-Blancard P, Bosonnet S, et al.: [Oral terbinafine-induced plantar pustular psoriasis]. [French] Ann Dermatol Venereol 127: 279-281, 2000.
26. Szepietowski JC: Terbinafine exacerbates psoriasis: case report with a literature review. Acta Dermatovenerol Croat 11: 17-21, 2003.
27. Gupta AK, Sibbald RG, Knowles SR, et al.: Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug-induced psoriasis. J Am Acad Dermatol 36: 858-862, 1997.
28. Tjiu JW, Tsai TF, Chu CY: Severe generalized pustular psoriasis provoked by oral terbinafine. Dermatol Sinica 22: 187-192, 2004.